You searched for "acuity"
Choroidal vascularity in NAION
The authors present a cross-sectional, non-interventional study of healthy volunteers and those with non-arteritic anterior ischaemic optic neuropathy (NAION) recruited over a six-month period at a single site. NAION is the most common cause of acute optic neuropathy over the...
Prisms to treat AACE
Of 128 patients reviewed with binocular dysfunction, 30 (23.4%) had acute acquired concomitant esotropia (AACE). These patients complained of sudden onset diplopia at distance with no or moderate problems at near. There was no previous history of strabismus. Mean age...
A survey of neuro-ophthalmologists on use of corticosteroids in giant cell arteritis
While corticosteroids are the mainstay of treatment in giant cell arteritis (GCA), the type, dose, route and duration of treatment remains controversial. The authors surveyed 180 neuro-ophthalmologists on their use of this treatment via email in a two-month period. Results...
Does methanol poisoning require ophthalmic investigation?
The authors report a case series of 21 patients (41 eyes) diagnosed with acute methanol poisoning following an outbreak in Tunisia in 2020. All patients underwent a complete ophthalmological examination including visual fields, colour vision test and optical coherence tomography...
Efficacy of augmented-dosed surgery versus botulinum toxin A injection for acute acquired concomitant esotropia
This is a retrospective study of 104 patients diagnosed with acute acquired concomitant esotropia (AACE) between 2020 and 2022. Potential factors that influence the dose-response of bilateral medial rectus recession (MRec) and the rate and risk factors for ACCE relapse...
Long-term outcomes after acute primary angle closure
This is a retrospective observational study including 121 eyes of 117 consecutive patients with acute primary angle closure (APAC) over a four-year period, between 1 January 2010 to 31 December 2014. Seventy-three percent had achieved visual acuities of ≥ 6/12,...
BTA as a first-line treatment option for acute acquired comitant esotropia
This study presents results of a single-centre institute use of botulinum toxin A (BTA) as an initial treatment choice for acute acquired comitant esotropia (AACE). This was a prospective observational case series study of 72 patients (49 male, 23 female)...
Use of reduced volume BT as a treatment option for acute onset comitant esotropia
In this study, the effectiveness and safety of botulinum toxin (BT) for patients with acute acquired comitant esotropia (AACE) and deviation ≤25PD was investigated with comparison of results to conservative prism therapy. Botulinum toxin was undertaken without electromyographic guidance and...BEECS 2026 Annual Meeting
British Emergency Eye Care Society 11th Annual Meeting
Surgical outcomes for acute acquired comitant esotropia with vs without prism adaptation testing
The aim of this study was to assess the efficacy of preoperative prism adaptation test (PAT) in cases of acute acquired comitant esotropia (AACE) in an Indian population. This was a prospective study of 40 patients. 20 patients had 1...
